Alhubaishi Alaa, Almutairi Maha A, Alasqah Malak A, Alharthi Shihanah H, Alqahtani Abdulhadi M, Alnajjar Lina I
Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Collage of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Cardiol Res. 2023 Aug;14(4):302-308. doi: 10.14740/cr1500. Epub 2023 Jul 12.
Stroke is a leading cause of disability and death worldwide. Globally, stroke affects 13.7 million individuals every year. Several studies have shown an increase in the rehospitalization rate among stroke patients caused by non-adherence to secondary prevention as recommended by the American Heart Association/American Stroke Association (AHA/ASA) guideline. The aim of this study was to evaluate physicians' compliance with secondary prevention of stroke upon patients' discharge.
A retrospective chart review study was conducted at King Fahad Medical City. The primary outcome of this study was the number of patients discharged with the recommended medications for the secondary prevention of ischemic stroke (IS). The data were collected from the patient's medical record files and analyzed using the Statistical Package for the Social Sciences (SPSS).
Of the 675 patients who were screened for eligibility, 507 were included and 168 were excluded. The mean age of the patients was 59.5 (± 15.6) years. Of the 507 patients, 181 (35.7%) had a history of previous stroke. Overall, 376 (74%) stroke patients were discharged with appropriate secondary prevention recommendation per AHA/ASA guideline.
This study stresses the importance of compliance with the AHA/ASA guideline for secondary stroke prevention and highlights the role of pharmacists in the stroke unit in which it is necessary to ensure that all stroke patients are discharged with the recommended medications to reduce recurrent stroke.
中风是全球致残和致死的主要原因。在全球范围内，中风每年影响1370万人。多项研究表明，由于未遵循美国心脏协会/美国中风协会（AHA/ASA）指南推荐的二级预防措施，中风患者的再住院率有所上升。本研究的目的是评估医生在患者出院时对中风二级预防的依从性。
在法赫德国王医疗城进行了一项回顾性病历审查研究。本研究的主要结果是出院时开具缺血性中风（IS）二级预防推荐药物的患者数量。数据从患者的病历档案中收集，并使用社会科学统计软件包（SPSS）进行分析。
在675名筛查合格的患者中，507名被纳入，168名被排除。患者的平均年龄为59.5（±15.6）岁。在507名患者中，181名（35.7%）有中风病史。总体而言，根据AHA/ASA指南，376名（74%）中风患者出院时获得了适当的二级预防推荐。
本研究强调了遵循AHA/ASA中风二级预防指南的重要性，并突出了药剂师在中风单元中的作用，即有必要确保所有中风患者出院时都开具推荐药物以减少中风复发。
